Data / Form D filings / Clear Labs, Inc.
Clear Labs, Inc.: Form D filings
Clear Labs, Inc., a biotechnology company in San Carlos, CA, filed 6 Form D notices with the SEC between 2014 and 2024. The latest, on December 30, 2024, reports $29.1 million sold of a $50 million offering to 33 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1559 Industrial Road, San Carlos, CA, 94070
- Phone
- (650) 257-3304
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1595806
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 30, 2024 | New notice | $50,000,000 | $29,062,615 | $20,937,385 | 33 | Dec 12, 2024 | sec.gov |
| May 28, 2021 | New notice | $70,000,000 | $59,999,933 | $10,000,067 | 30 | May 13, 2021 | sec.gov |
| May 19, 2020 | Amendment | $40,999,994 | $39,538,382 | $1,461,612 | 28 | Oct 24, 2018 | sec.gov |
| Oct 30, 2018 | New notice | $21,000,000 | $19,337,987 | $1,662,013 | 15 | Oct 24, 2018 | sec.gov |
| Sep 15, 2015 | New notice | $6,500,000 | $6,179,911 | $320,089 | 21 | Aug 31, 2015 | sec.gov |
| Jan 3, 2014 | New notice | $1,500,000 | $1,049,999 | $450,001 | 6 | Oct 2, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Greg Yap | Director | |
| Gaurav Garg | Director | |
| Mostafa Ronaghi | Director | |
| Sasan Amini | Executive Officer, Director | |
| Ming Fang | Director | |
| Ramin Khaksar | Executive Officer | |
| Edward Fan | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Dec 30, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Clear Labs, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.